WNT3A and neuroblastoma: Likewise, we provide evidence for Wnt/FZD2 activity in high-risk NB cell lines by showing increased phospho-LRP6 and active β-catenin levels in NB cells treated with recombinant Wnt3a, consistent with canonical β-catenin signaling.